Atrial fibrillation echocardiography or ultrasound: Difference between revisions

Jump to navigation Jump to search
m (Bot: Adding CME Category::Cardiology)
No edit summary
Line 15: Line 15:
|}
|}
{{Template:Atrial fibrillation}}
{{Template:Atrial fibrillation}}
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} {{Anahita}}


==Overview==
==Overview==
Line 21: Line 21:


==Echocardiography==
==Echocardiography==
Echocardiography is essential to identify the following characteristics in the setting of atrial fibrillation:
[[Echocardiography]] is essential to identify the following characteristics in the setting of [[atrial fibrillation]]:
* [[Valvular heart disease]]
* [[Valvular heart disease]]
* Left and right atrial size
* Left and right [[atrium|atrial]] size
* LV size and function
* [[Left ventricle]] ([[Left ventricle|LV]]) size and function
* Peak RV pressure ([[pulmonary hypertension]])
* Peak [[right ventricle]] [[pressure]] ([[pulmonary hypertension]])
*[[LV hypertrophy]]
*[[Left ventricular hypertrophy]]
* LA [[thrombus]] (low sensitivity)
* [[Left atrium]] [[thrombus]] (low [[Sensitivity (tests)|sensitivity]])
* Pericardial disease
* [[Pericarditis|Pericardial disease]]


===Transesophageal Echocardiography (TEE)===
===Transesophageal Echocardiography (TEE)===
*A normal [[echocardiography]] (transthoracic or TTE) has a low sensitivity for identifying [[thrombus|thrombi]] (blood clots) in the heart. If this is suspected, e.g. when planning urgent electrical [[cardioversion]] a [[Echocardiogram#Transesophageal echocardiogram|transesophageal echocardiogram]] (TEE) is preferred.<ref name="pmid16908781">Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2006) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16908781 ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.] ''Circulation'' 114 (7):e257-354. [http://dx.doi.org/10.1161/CIRCULATIONAHA.106.177292 DOI:10.1161/CIRCULATIONAHA.106.177292] PMID: [http://pubmed.gov/16908781 16908781]</ref>
*A normal [[echocardiography]] ([[Standard views and measurements in transthoracic echocardiography|transthoracic]] or [[Echocardiography|TTE]]) has a low [[Sensitivity (tests)|sensitivity]] for identifying [[thrombus|thrombi]] ([[Thrombus|blood clots]]) in the [[heart]]. If [[atrial fibrillation]] is suspected and urgent electrical [[cardioversion]] is planned a [[Echocardiogram#Transesophageal echocardiogram|transesophageal echocardiogram]] ([[Echocardiography|TEE]]) is preferred.<ref name="pmid16908781">Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2006) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16908781 ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.] ''Circulation'' 114 (7):e257-354. [http://dx.doi.org/10.1161/CIRCULATIONAHA.106.177292 DOI:10.1161/CIRCULATIONAHA.106.177292] PMID: [http://pubmed.gov/16908781 16908781]</ref>


*The TEE has much better visualization of the [[left auricular appendix|left atrial appendage]] than transthoracic echocardiography. This structure, located in the [[left atrium]], is the place where thrombus most commonly is formed in the setting of atrial fibrillation or flutter. TEE has a very high sensitivity for locating [[thrombus]] in this area and can also detect sluggish blood flow in this area that is suggestive of thrombus formation.
*The [[Echocardiography|TEE]] has much better visualization of the [[left auricular appendix|left atrial appendage]] than [[Echocardiography|transthoracic echocardiography]]. This structure, located in the [[left atrium]], is the place where [[thrombus]] most commonly is formed in the setting of [[atrial fibrillation]] or [[atrial flutter]]. [[Echocardiography|TEE]] has a very high [[Sensitivity (tests)|sensitivity]] for locating [[thrombus]] in this area and can also detect sluggish [[blood]] flow in this area that is suggestive of [[thrombus]] formation.


*If no thrombus is seen on TEE, the incidence of [[stroke]] immediately after cardioversion is performed is very low.
*If no [[thrombus]] is seen on [[Echocardiography|TEE]], the incidence of [[stroke]] immediately after [[cardioversion]] is very low.


===Transthoracic Echocardiography (TTE)===
===Transthoracic Echocardiography (TTE)===
*A [[Transthoracic echocardiography|transthoracic echocardiogram]] is generally performed in newly diagnosed [[AF]], as well as if there is a major change in the patient's clinical state. This [[ultrasound]]-based scan of the [[heart]] may help identify [[valvular heart disease]] (which may increase the risk of [[stroke]] manifold), left and right atrial size (which indicates likelihood that [[AF]] may become permanent), left ventricular size and function, peak right ventricular pressure ([[pulmonary hypertension]]), presence of [[left ventricular hypertrophy]] and pericardial disease.<ref name="pmid16908781">Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2006) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16908781 ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.] ''Circulation'' 114 (7):e257-354. [http://dx.doi.org/10.1161/CIRCULATIONAHA.106.177292 DOI:10.1161/CIRCULATIONAHA.106.177292] PMID: [http://pubmed.gov/16908781 16908781]</ref>
*A [[Transthoracic echocardiography|transthoracic echocardiogram]] is generally performed in newly [[diagnosis|diagnosed]] [[atrial fibrillation]] ([[AF]]), as well as if there is a major change in [[patient]]'s clinical state. This [[ultrasound]]-based scan of the [[heart]] may help identify [[valvular heart disease]] (which may increase the risk of [[stroke]]), [[atrium|left and right atrial]] size (which indicates likelihood of [[atrial fibrillation]] changing into the permanent type), [[left ventricle|left ventricular size]] and dysfunction, peak [[right ventricle|right ventricular pressure]] ([[pulmonary hypertension]]), presence of [[left ventricular hypertrophy]] and [[Pericarditis|pericardial disease]].<ref name="pmid16908781">Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2006) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16908781 ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.] ''Circulation'' 114 (7):e257-354. [http://dx.doi.org/10.1161/CIRCULATIONAHA.106.177292 DOI:10.1161/CIRCULATIONAHA.106.177292] PMID: [http://pubmed.gov/16908781 16908781]</ref>


*Significant enlargement of both the left and right atria is associated with long-standing [[atrial fibrillation]] and, if noted at the initial presentation of [[atrial fibrillation]], suggests that the [[atrial fibrillation]] is likely of a longer duration than the individual's symptoms.
*Significant enlargement of both the [[atrium|left and right atria]] is associated with long-standing [[atrial fibrillation]] and, if noted at the initial presentation of [[atrial fibrillation]], suggests that the [[atrial fibrillation]] is likely of a longer duration than the individual's [[symptoms]].


==References==
==References==

Revision as of 20:04, 1 August 2021



Resident
Survival
Guide
File:Critical Pathways.gif

Sinus rhythm
Atrial fibrillation

Atrial Fibrillation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups

Postoperative AF
Acute Myocardial Infarction
Wolff-Parkinson-White Preexcitation Syndrome
Hypertrophic Cardiomyopathy
Hyperthyroidism
Pulmonary Diseases
Pregnancy
ACS and/or PCI or valve intervention
Heart failure

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples
A-Fib with LBBB

Chest X Ray

Echocardiography

Holter Monitoring and Exercise Stress Testing

Cardiac MRI

Treatment

Rate and Rhythm Control

Cardioversion

Overview
Electrical Cardioversion
Pharmacological Cardioversion

Anticoagulation

Overview
Warfarin
Converting from or to Warfarin
Converting from or to Parenteral Anticoagulants
Dabigatran

Maintenance of Sinus Rhythm

Surgery

Catheter Ablation
AV Nodal Ablation
Surgical Ablation
Cardiac Surgery

Specific Patient Groups

Primary Prevention

Secondary Prevention

Supportive Trial Data

Cost-Effectiveness of Therapy

Case Studies

Case #1

Atrial fibrillation echocardiography or ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial fibrillation echocardiography or ultrasound

CDC on Atrial fibrillation echocardiography or ultrasound

Atrial fibrillation echocardiography or ultrasound in the news

Blogs on Atrial fibrillation echocardiography or ultrasound

Directions to Hospitals Treating Atrial fibrillation echocardiography or ultrasound

Risk calculators and risk factors for Atrial fibrillation echocardiography or ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Anahita Deylamsalehi, M.D.[3]

Overview

Performing an echocardiogram in the setting of atrial fibrillation is essential to identify certain characteristics of the heart, including valvular heart disease, hypertrophy, presence of thrombus, the size and function of the left ventricle, the size of the atria, and the possible presence of pericardial disease.

Echocardiography

Echocardiography is essential to identify the following characteristics in the setting of atrial fibrillation:

Transesophageal Echocardiography (TEE)

Transthoracic Echocardiography (TTE)

References

Template:WH Template:WS CME Category::Cardiology